Main publications

• Sarkozy, C. et al. (2021) Innovative therapies based on molecular orientation in patients with relapse and refractory diffuse large B-cell lymphoma: Results of LNH-EP1 study.  V. Am J Hematol;96(10):E376-E379
• El Halabi, L. et al. (2021)  Expression of the Immune Checkpoint Regulators LAG-3 and TIM-3 in Classical Hodgkin Lymphoma. Clin Lymphoma Myeloma Leuk;21(4):257-266.

Team members

• Head of the platform: Stéphane De Botton, M.D.
• Lab manager: Cyril Quivoron, PhD (cyril.quivoron@gustaveroussy.fr)
• Marjorie Sabourin-Cousin, Technician
• Chaima Habib Allah, Technician

Activities

Reception and qualification of biological samples collected from patients with hematological malignancies treated at Gustave Roussy.  Translational research projects are addressed after validation by lab steering committee. Research projects are proposed by the Hematology Committee or DITEP members; contracts are validated by Gustave Roussy Transfert.

Les 16 et 17 novembre 2021 aura lieu à Paris le premier congrès virtuel du Centre International des Cancers Thoraciques (CICT), regroupant Gustave Roussy et l’hôpital Marie-Lannelongue et l’hôpital Paris Saint-Joseph, ainsi que leurs trois expertises respectives et complémentaires autour des cancers du thorax : la prise en charge chirurgicale, la prise en charge oncologique et la radiothérapie. Des spécialistes exposeront l’état de la recherche en matière de dépistage, d’environnement et de traitements locaux de ces pathologies.